摘要
Background: Telomerase reverse transcriptase promoter (TERT-p) mutation has been frequently found, but associated with contrary prognosis, in both low-grade gliomas and glioblastomas. For the low-grade gliomas (Grades II-III), TERT-p mutant patients have a better prognosis than the wildtype patients, whereas for the GBMs (Grade IV), TERT-p mutation is related to a poor prognosis. We hypothesize that there exist high-risk patients in LGGs who share GBM-like molecular features, including TERT-p mutation, and need more intensive treatment than other LGGs. A molecular signature is needed to identify these high-risk patients for an accurate and timely treatment.Methods: Using the within-sample relative expression orderings of gene pairs, we identified the gene pairs with significantly stable REOs, respectively, in both the TERT-p mutant LGGs and GBMs but with opposite directions in the two groups. These reversely stable gene pairs were used as the molecular signature to stratify the LGGs into high-risk and low-risk groups.Results: A signature consisting of 21 gene pairs was developed, which can classify LGGs into two groups with significantly different overall survival. The high-risk group has a similar genetic mutation profile and a similar survival profile as GBMs, and these high-risk tumors may progress to a more malignant state.Conclusion: The 21 gene-pair signature based on REOs is capable of identifying high-risk patients in LGGs and guiding the clinical choice for appropriate and timely intervention.
学科与关键词
- Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma PatientsWang, Qi; He, Zongze*; Chen, Yong*Cancer Control, 2019, 26(1): 1073274819855118.
- TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type GliomaGao, Mengqi; Lin, Yi*; Liu, Xing; Zhao, Zheng; Zhu, Zhiyuan; Zhang, Hongbo; Ban, Yunchao; Bie, Yanan; He, Xiaozheng; Sun, Xiang; Zhang, Shizhong*Frontiers in Cell and Developmental Biology, 2021, 9: 654407.被引 10
- Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRIZhang, Hongbo; Zhang, Hanwen; Zhang, Yuze; Zhou, Beibei; Wu, Lei; Lei, Yi*; Huang, Biao*Journal of Magnetic Resonance Imaging, 2023, 58(5): 1441-1451.被引 4
